Rosiglitazone reduces breast cancer risk in Taiwanese female patients with type 2 diabetes mellitus.
about
Deciphering the Roles of Thiazolidinediones and PPARγ in Bladder Cancer.Metformin Inhibits Tumorigenesis and Tumor Growth of Breast Cancer Cells by Upregulating miR-200c but Downregulating AKT2 Expression.Sitagliptin and oral cancer risk in type 2 diabetes patients.Indole and 2,4-Thiazolidinedione conjugates as potential anticancer modulators
P2860
Rosiglitazone reduces breast cancer risk in Taiwanese female patients with type 2 diabetes mellitus.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 08 December 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Rosiglitazone reduces breast c ...... with type 2 diabetes mellitus.
@en
Rosiglitazone reduces breast c ...... with type 2 diabetes mellitus.
@nl
type
label
Rosiglitazone reduces breast c ...... with type 2 diabetes mellitus.
@en
Rosiglitazone reduces breast c ...... with type 2 diabetes mellitus.
@nl
prefLabel
Rosiglitazone reduces breast c ...... with type 2 diabetes mellitus.
@en
Rosiglitazone reduces breast c ...... with type 2 diabetes mellitus.
@nl
P2860
P356
P1433
P1476
Rosiglitazone reduces breast c ...... with type 2 diabetes mellitus.
@en
P2093
Chin-Hsiao Tseng
P2860
P304
P356
10.18632/ONCOTARGET.13824
P407
P577
2016-12-08T00:00:00Z